Zobrazeno 1 - 10
of 90
pro vyhledávání: '"Fast Track Clinical Research"'
Autor:
Carla Spazzolini, Isabelle Denjoy, Roel L.H.M.G. Spätjens, Peter J. Schwartz, Maria Christina Kotta, Paul A. Brink, Cristina Moreno, Kristina H. Haugaa, Sandrine R.M. Seyen, Maria Shkolnikova, Federica Dagradi, Lia Crotti, Marshall Heradien, Paul G.A. Volders, Silvia Castelletti, Matteo Pedrazzini
Publikováno v:
Eur Heart J
European Heart Journal, 42(46), 4743-4755. Oxford University Press
European Heart Journal, 42(46), 4743-4755. Oxford University Press
Aims Mutation type, location, dominant-negative I Ks reduction, and possibly loss of cyclic adenosine monophosphate (cAMP)-dependent I Ks stimulation via protein kinase A (PKA) influence the clinical severity of long QT syndrome type 1 (LQT1). Given
Autor:
Subodh Verma, Milton Packer, Stefan D. Anker, Carolyn S.P. Lam, Daniel Cotton, Stuart J. Pocock, Martina Brueckmann, David Sim, Janet Schnee, Javed Butler, Egon Pfarr, Gerasimos Filippatos, João Pedro Ferreira, Hiroyuki Tsutsui, Faiez Zannad, Naveed Sattar
Publikováno v:
European Heart Journal, 42(43), 4442-4451. Oxford University Press
European Heart Journal
European Heart Journal, Oxford University Press (OUP): Policy B, 2021, pp.ehab360. ⟨10.1093/eurheartj/ehab360⟩
European Heart Journal
European Heart Journal, Oxford University Press (OUP): Policy B, 2021, pp.ehab360. ⟨10.1093/eurheartj/ehab360⟩
Aims The aim of this article is to explore the influence of region and race/ethnicity on the effects of empagliflozin in the Empagliflozin Outcome Trial in Patients with Chronic Heart Failure and a Reduced Ejection Fraction (EMPEROR-Reduced) trial. M
Autor:
Eisuke Hida, Kiyose Nakagawa, Ayako Okura, Akihiro Nomura, Kazuomi Kario, Noriko Harada, Tomoyuki Tanigawa
Publikováno v:
European Heart Journal
Aims Digital therapeutics is a new approach to facilitate the non-pharmacological treatment of hypertension using software programmes such as smartphone applications and/or device algorithms. Based on promising findings from a small pilot trial, the
Autor:
Anna Maria Langkilde, Scott D. Solomon, Olof Bengtsson, John J.V. McMurray, Mikhail Kosiborod, Kieran F. Docherty, James P. Curtain, Felipe Martinez, Lars Køber, Piotr Ponikowski, Pardeep S. Jhund, Marc S. Sabatine, Mark C. Petrie, Silvio E. Inzucchi, Mikaela Sjöstrand
Publikováno v:
Eur Heart J
Curtain, J P, Docherty, K F, Jhund, P S, Petrie, M C, Inzucchi, S E, Køber, L, Kosiborod, M N, Martinez, F A, Ponikowski, P, Sabatine, M S, Bengtsson, O, Langkilde, A M, Sjöstrand, M, Solomon, S D & McMurray, J J V 2021, ' Effect of dapagliflozin on ventricular arrhythmias, resuscitated cardiac arrest, or sudden death in DAPA-HF ', European Heart Journal, vol. 42, no. 36, pp. 3727-3738 . https://doi.org/10.1093/eurheartj/ehab560
Curtain, J P, Docherty, K F, Jhund, P S, Petrie, M C, Inzucchi, S E, Køber, L, Kosiborod, M N, Martinez, F A, Ponikowski, P, Sabatine, M S, Bengtsson, O, Langkilde, A M, Sjöstrand, M, Solomon, S D & McMurray, J J V 2021, ' Effect of dapagliflozin on ventricular arrhythmias, resuscitated cardiac arrest, or sudden death in DAPA-HF ', European Heart Journal, vol. 42, no. 36, pp. 3727-3738 . https://doi.org/10.1093/eurheartj/ehab560
Aims The aim of this study was to examine the effect of dapagliflozin on the incidence of ventricular arrhythmias and sudden death in patients with heart failure and reduced ejection fraction (HFrEF). Methods and results In a post hoc analysis of DAP
Autor:
Nicholas Marston, Michelle O'Donoghue
Publikováno v:
Eur Heart J
AIMS: Guidelines recommend the use of potent P2Y(12) inhibitors over clopidogrel for the reduction of ischaemic events in patients with acute coronary syndrome (ACS). However, this comes at the expense of increased bleeding. A guided selection of P2Y
Autor:
Yousif Ahmad, Bahira Shahim, Björn Redfors, Gregg W. Stone, Megha Prasad, Sripal Bangalore, Mahesh V. Madhavan, James P. Howard, Ori Ben-Yehuda, Martin B. Leon, Azim Naqvi
Publikováno v:
Eur Heart J
Aims Contemporary 2nd-generation thin-strut drug-eluting stents (DES) are considered standard of care for revascularization of patients undergoing percutaneous coronary intervention. A previous meta-analysis of 10 randomized controlled trials (RCTs)
Autor:
Andrew Tinker
Publikováno v:
Eur Heart J
AIMS: Mutation type, location, dominant-negative I(Ks) reduction, and possibly loss of cyclic adenosine monophosphate (cAMP)-dependent I(Ks) stimulation via protein kinase A (PKA) influence the clinical severity of long QT syndrome type 1 (LQT1). Giv
Autor:
Baldi, Enrico, Sechi, Giuseppe Maria, Mare, Claudio, Canevari, Fabrizio, Brancaglione, Antonella, Primi, Roberto, Klersy, Catherine, Palo, Alessandra, Contri, Enrico, Ronchi, Vincenza, Beretta, Giorgio, Reali, Francesca, Parogni, Pierpaolo, Facchin, Fabio, Rizzi, Ugo, Bussi, Daniele, Ruggeri, Simone, Oltrona Visconti, Luigi, Savastano, Simone, Compagnoni, Sara, Fracchia, Rosa, Cuzzoli, Antonio, Pagliosa, Andrea, Matiz, Guido, Russo, Alessandra, Vecchi, Andrea Lorenzo, Fantoni, Cecilia, Fava, Cristian, Franzosi, Cinzia, Vimercati, Claudio, Franchi, Dario, Storti, Enrico, Taravelli, Erika, Giovenzana, Fulvio, Buetto, Giovanni, Garzena, Guido, Iotti, Giorgio Antonio, Villa, Guido Francesco, Botteri, Marco, Caico, Salvatore Ivan, Cominesi, Irene Raimondi, Carnevale, Livio, Caresani, Matteo, Luppi, Mario, Migliori, Maurizio, Centineo, Paola, Genoni, Paola, Bertona, Roberta, De Ponti, Roberto, Osti, Riccardo, Buratti, Stefano, Danzi, Gian Battista, Marioni, Arianna, De Pirro, Antonella, Molinari, Simone, Sgromo, Vito, Musella, Valeria, Paglino, Martina, Mojoli, Francesco, Lusona, Bruno, Pagani, Michele, Curti, Moreno
Publikováno v:
European Heart Journal
Aims An increase in out-of-hospital cardiac arrest (OHCA) incidence has been reported in the very early phase of the COVID-19 epidemic, but a clear demonstration of a correlation between the increased incidence of OHCA and COVID-19 is missing so far.
Autor:
Muthiah Vaduganathan, Brian Claggett, John J.V. McMurray, Jirí Widimský, Petar M. Seferovic, Martin Lefkowitz, Pardeep S. Jhund, Milton Packer, Adel R. Rizkala, Scott D. Solomon, Victor Shi
Publikováno v:
European Heart Journal
Aims The PARADIGM-HF and PARAGON-HF trials tested sacubitril/valsartan against active controls given renin–angiotensin system inhibitors (RASi) are ethically mandated in heart failure (HF) with reduced ejection fraction and are used in the vast maj
Autor:
Colin Berry, Hannah Bayes
Publikováno v:
European Heart Journal
Aims Long-term sequelae may occur after SARS-CoV-2 infection. We comprehensively assessed organ-specific functions in individuals after mild to moderate SARS-CoV-2 infection compared with controls from the general population. Methods and results Four